Asymchem Dunhua Manufacturing Facility Successfully Completes Korean MFDS Inspection

Friday, December 1, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

TIANJIN, China, Nov. 30, 2017 /PRNewswire/ -- Asymchem Laboratories (Tianjin) Co., Ltd.

(SHE: 002821, "Asymchem") today announced that its API facility in Dunhua city, Jilin province, P. R. China ("Dunhua"), has successfully passed an inspection for GMP compliance by the
Korean Ministry of Food and Drug Safety (MFDS). The 3-day inspection was conducted between September 5-7, 2017 for a customer specific intermediate product which is manufactured, packed and distributed by Asymchem's Dunhua site. The site was found to be compliant with the principles and guidelines of Good Manufacturing Practice (GMP) for commercial activities. This was Asymchem Dunhua's first Korean MFDS inspection.

Dr. Hao Hong, CEO and Chairman of the Board of Asymchem Group, responded by stating, "We are encouraged by the continued success of agency audits for the Dunhua manufacturing site, and remain committed to improve our quality programs to ensure continued compliance to meet the highest quality standards in the manufacture of API's".

About Asymchem

Asymchem is a CMC CDMO with over 20 years' expertise in developing innovative and sustainable processes for development to commercial APIs and HPAPIs. Operating out of six state of the art facilities in China and proficient in a number of niche technologies, including biotransformation, flow chemistry, highly-potent compounds, asymmetric synthesis, high-pressure and low- temperature chemistry, Asymchem is the main partner of choice for the global pharmaceutical industry.

View original content:http://www.prnewswire.com/news-releases/asymchem-dunhua-manufacturing-facility-successfully-completes-korean-mfds-inspection-300564832.html

SOURCE Asymchem Laboratories (Tianjin) Co., Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store